FDA Calls for Testing Before Treatment With Widely Used Chemotherapies

By News Health
37 minutes Ago

(MedPage Today) — Oncology specialists should inform patients about a risk of serious toxicity related to dihydropyrimidine dehydrogenase (DPD) deficiency and should test for DPYD variants before starting treatment with capecitabine (Xeloda) and…

Source link : https://www.medpagetoday.com/hematologyoncology/othercancers/119774

Author :

Publish date : 2026-02-06 17:59:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Intrusive thoughts? John has a room for that

Emails Undermine RFK Jr.'s Testimony on His Trip to Samoa Before a Measles Outbreak

Use of GLP-1 Drugs Under Scrutiny at Winter Olympics

Kate Middleton's Cancer Battle; RFK Jr. Claims Keto Can 'Cure'; FDA Chief's Warning

Comedy on Prescription? Pilot Raises Hopes for NHS Care

Study Maps Extensive Disease Links Beyond Childhood Eczema